Peer Coaching for Congenital Heart Disease
(CHASM in ACHD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if peer coaching can help young adults with congenital heart disease manage their condition more effectively. Participants will either receive regular educational newsletters or participate in a peer coaching program for six months. Those between 18 and 26, with congenital heart disease, and who are patients at a Duke pediatric cardiology clinic may qualify. Participants must also have access to a smartphone.
As an unphased study, this trial provides a unique opportunity to contribute to innovative research that could enhance support for managing congenital heart disease.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this peer coaching intervention is safe for young adults with congenital heart disease?
Research has shown that peer coaching, including exercise programs, is safe for adults and children with congenital heart disease. These programs assist individuals in managing their condition. Although a recent study on a similar peer health coaching program did not demonstrate a significant reduction in systolic blood pressure (the top number in a blood pressure reading), participants reported an overall improvement in well-being. No reports of serious side effects from peer coaching exist, making it a well-tolerated option for those considering participation.12345
Why are researchers excited about this trial?
Researchers are excited about peer health coaching for congenital heart disease because it offers a unique, personalized approach that current treatments don't provide. Unlike traditional medical care that focuses primarily on medication and surgical interventions, peer coaching involves support from individuals who have firsthand experience with the condition. This method can enhance emotional well-being and empower patients through shared experiences and support. By fostering a supportive community, peer coaching aims to improve patients' quality of life and adherence to medical advice, something standard treatments might not fully address.
What evidence suggests that peer health coaching is effective for congenital heart disease?
Research has shown that peer health coaching can benefit people with congenital heart disease. This trial includes a Peer Coaching arm, where participants receive a 6-month peer health coaching intervention. This method pairs individuals with peers who have successfully managed similar health issues. Other studies have found that health coaching slightly but significantly improves health outcomes, such as blood sugar levels. Although specific data for congenital heart disease is limited, participants often report a better quality of life after receiving coaching. Early findings suggest that peer coaching could help young adults transition more smoothly to adult heart care.12367
Who Is on the Research Team?
Richard A Krasuski, MD
Principal Investigator
Duke University
Gary Maslow, MD, MPH
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for young adults aged 18-26 with congenital heart disease who are patients at a Duke pediatric cardiology clinic and have access to a smartphone. It's not suitable for individuals with cognitive delays or those attending an adult cardiology clinic.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-month peer health coaching intervention or education-only material
Follow-up
Participants are monitored for changes in health-related quality of life, patient activation, self-management, and transition readiness
Long-term follow-up
Evaluate successful transfer of participants from pediatric to adult cardiology care
What Are the Treatments Tested in This Trial?
Interventions
- Peer Health Coaching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Adult Congenital Heart Association
Collaborator